Bioactivity:

BDA-366 specifically targets the BH4 domain of Bcl2 BDA-366 and suppresses human myeloma growth. BDA-366 induces robust apoptosis in MM cell lines and primary MM cells by inducing BCL2 conformational change. Delivery of BDA-366 substantially suppressed th

CAS nr:

1821496-27-8

Purity:

98%

Molecular Weight:

423,26

SMILES:

CCN(CC)C[C@@H](O)CNc1ccc(NC[C@H]2CO2)c2C(=O)c3ccccc3C(=O)c12

Formula:

C24H29N3O4

Pathway:

Apoptosis

Target:

BCL